Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results From Study RA-BALANCE
mediaposted on 2020-09-01, 09:11 authored by Yue Yang, Xing-Fu Li, Xiao Zhang, Chun-De Bao, Jian-Kang Hu, Jian-Hua Xu, Xiang-Pei Li, Jian Xu, Dong-Yi He, Zhi-Jun Li, Guo-Chun Wang, Han-Jun Wu, Fei Ji, Lu-Jing Zhan, Cristiano A. F. Zerbini, Zhan-Guo Li
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.